Why is Mukka Proteins falling/rising?

As of 16-Sep, Mukka Proteins Ltd is currently priced at 27.96, reflecting an increase of 0.22 or 0.79%. The stock has shown a positive movement, gaining 1.19% over the last two days, although it remains below the 5-day, 50-day, 100-day, and 200-day moving averages. Despite this recent uptick, the stock has underperformed significantly over the past year, with a decline of 37.24%. The company has faced challenges, including a high Debt to EBITDA ratio of 4.36 times and a low Return on Capital Employed (ROCE) of 9.48%, indicating poor management efficiency and profitability. Additionally, the company has reported negative results for six consecutive quarters, with substantial declines in net sales and profits, which may contribute to investor skepticism.
In the broader market context, Mukka Proteins' short-term return of 0.39% over the past week is notably lower than the Sensex's gain of 1.58%. This underperformance is indicative of the stock's struggles compared to the benchmark, further compounded by a decrease in institutional investor participation, which has fallen by 0.65% in the last quarter. The overall market sentiment appears to favor stocks with healthier fundamentals, as evidenced by the Sensex's positive performance, while Mukka Proteins continues to grapple with significant operational challenges and declining investor confidence.